Kore Private Wealth’s Gilead Sciences GILD Stock Holding History

Kore Private Wealth’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-16,357	Closed	-$1.14M	–	373
2021 Q3	$1.14M	Buy	16,357 +884	+6%	+$62.1K	0.12%	133
2021 Q2	$1.06M	Buy	15,473 +10,553	+214%	+$705K	0.12%	134
2021 Q1	$318K	Buy	4,920 +612	+14%	+$39.5K	0.04%	261
2020 Q4	$251K	Buy	4,308 +1,099	+34%	+$66.3K	0.04%	267
2020 Q3	$203K	Buy	3,209 +127	+4%	+$8.81K	0.04%	251
2020 Q2	$237K	Sell	3,082 -39	-1%	-$2.99K	0.05%	207
2020 Q1	$233K	Buy	3,121 +1,517	+95%	+$105K	0.06%	190
2019 Q4	$104K	Buy	+1,604	New	+$104K	0.02%	363
2019 Q2	–	Sell	-1,171	Closed	-$76K	–	445
2019 Q1	$76K	Buy	1,171 +42	+4%	+$2.79K	0.02%	321
2018 Q4	$71K	Buy	+1,129	New	+$78.9K	0.02%	315

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Kore Private Wealth's GILD Position: Q4 2021 in Review

Kore Private Wealth sold out of Gilead Sciences (GILD) in Q4 2021, closing a stake of 16,357 shares — an estimated $1.14M sold.

Kore Private Wealth first reported a position in GILD in Q4 2018 and held it in 10 quarters. The position peaked at $1.14M in Q3 2021. 1,682 funds tracked by Wall St. Rank hold GILD as of Q4 2021.

Kore Private Wealth reported no remaining Gilead Sciences position as of Q4 2021 after selling out during the quarter.
Kore Private Wealth sold 16,357 Gilead Sciences shares in Q4 2021, an estimated $1.14M.
Kore Private Wealth first reported a position in Gilead Sciences in Q4 2018 and held it in 10 quarters.
Kore Private Wealth's Gilead Sciences position peaked at $1.14M in Q3 2021.
1,682 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2021.

Based on Kore Private Wealth's 13F filing for Q4 2021, filed 11 Feb 2022.